Oral administration of n-acetyl cysteine in the prophylaxis of “meconium ileus equivalent” - 07/10/17
Summary |
A 26-year-old adult with well-documented cystic fibrosis, but with relatively mild pulmonary involvement, was severely disabled by frequent severe attacks of abdominal pain and constipation. Treatment by pancreatic enzyme replacement and regular enemas did not bring about long-standing improvement. One year ago oral administration of n-acetyl cysteine was instituted, and since then the patient has been asymptomatic except for one brief episode of abdominal pain 6 months ago.
Le texte complet de cet article est disponible en PDF.† | Supported by Gastroenterology Training Grant No. 5T1-AM-5099 from the National Institutes of Health. Dr. Lillibridge was supported by a Postdoctoral Research Fellowship award No. 5-F2-AM-28,882-02 from the National Institute of Arthritis and Metabolic Disease, National Institutes of Health. The N-acetyl-cysteine was supplied by Mead Johnson Laboratories. |
Vol 71 - N° 6
P. 887-889 - décembre 1967 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?